Saint Luke's Mid America Heart Institute — Kansas City, Missouri

Saint Luke's Mid America Heart Institute is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Saint Luke's Mid America Heart Institute has participated in 9 clinical trials with 2 currently active.

Therapeutic areas: Chronic Heart Failure With Preserved Systolic Function, Heart Failure, COVID-19.

Sponsors: Saint Luke's Health System, Bayer, P+F Products + Features USA Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Luke's Mid America Heart Institute?

Saint Luke's Mid America Heart Institute has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Luke's Mid America Heart Institute conducted?

Saint Luke's Mid America Heart Institute has 9 clinical trials on record, with 2 currently active. Their work covers Chronic Heart Failure With Preserved Systolic Function, Heart Failure, COVID-19.

Is Saint Luke's Mid America Heart Institute accredited by Crixeo Health?

Yes — Saint Luke's Mid America Heart Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Saint Luke's Mid America Heart Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.